Arab Finance: Egyptian International Pharmaceutical Industries Co. (EIPICO) is aiming to achieve sales of more than EGP 6.5 billion this year, according to a press release on February 11th.
The firm’s preliminary financial results showed that EIPICO achieved over EGP 5 million in sales last year.
the results also revealed that EIPICO's exports stood at $54 million in 2023, making up a market share of 26% out of the total Egyptian exports.
EIPICO is an Egypt-based public shareholding company that operates in the pharmaceutical industry. It is a manufacturer and exporter of pharmaceuticals and holds license agreements with a group of international.